The Impact of Seropositivity on Systemic Bone Loss in Rheumatoid Arthritis—A 3-Year Interim Analysis of a Longitudinal Observational Cohort Study

The Impact of Seropositivity on Systemic Bone Loss in Rheumatoid Arthritis—A 3-Year Interim Analysis of a Longitudinal Observational Cohort Study

ObjectiveTo explore the impact of seropositivity on systemic bone loss in rheumatoid arthritis (RA).MethodsWe conducted an interim analysis of the RA registry. Patients were examined with dual-energy X-ray absorptiometry at baseline and again 3 years later. Participants were grouped into seropositiv...

Full description

Bibliographic Details
Main Authors: Shan-Fu Yu, Jia-Feng Chen, Ying-Chou Chen, Yu-Wei Wang, Chung-Yuan Hsu, Han-Ming Lai, Hsiao-Ru He, Chi-Hua Ko, Wen-Chan Chiu, Tien-Tsai Cheng
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Medicine
Subjects:
rheumatoid arthritis
bone mineral density
anti-cyclic citrullinated peptide antibodies
rheumatoid factor
fracture
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2022.885801/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2022.885801/full

Similar Items